Recommended

Register now: Enhancing biopharma workflows with the power of UV/Vis spectroscopy webinar
Download our brand new eBook: A practical guide to single-use filtration in biopharma.
Join us as we look at how the outsourcing of buffers is helping biopharma drug manufacturers to streamline their processes.
Discover more on how Polpharma API meets evolving regulatory guidance around N-nitrosamines control in APIs with Waters’ high-performance analysis instruments.
Learn more about leveraging real-world data, the practical applications of AI and adopting configurable LC/NC solutions.
Download this compendium to discover how hot-melt extrusion can help to overcome pharmaceutical formulation challenges

List view / Grid view

References

Carnell-Morris P, Kaszuba M, Pothecary M. Analytical techniques for faster development of drug delivery systems. European Pharmaceutical Review. 2017; 44-46

12 July 2017 | By , ,

References Global Markets and Technologies for Advanced Drug Delivery Systems BCC Research Reports PHM006K. March 2016. www.bccresearch.com/market-research/pharmaceuticals/advanced-drug-delivery-systems-tech-markets-report-phm006k.html [Accessed 08 November 2016]. Drug Delivery Systems: Getting Drugs to Their Targets in a Controlled Manner. National Institute of Biomedical Imaging and Bioengineering www.nibib.nih.gov/science-education/science-topics/drug-delivery-systems-getting-drugs-their-targets-controlled-manner [Accessed 8 November 2016].

Laffleur F. Mucosal delivery – is this the next level in drug delivery?. European Pharmaceutical Review. 2017;3:38-40

12 July 2017 | By

References Laffleur F. Thiomers, mucoadhesion and oral delivery of biomacromolecules. Curr. Drug ther. [Internet]. 2014;9:56-62. Kharenko EA, Larionova NI, Demina NB. Mucoadhesive drug delivery systems (Review). Pharm. Chem. J. 2009. p200-8. Boddupalli B, Mohammed Z, Nath R, Banji D. Mucoadhesive drug delivery system: An overview. J. Adv. Pharm. Technol. Res.…

Courtney P et al. Freeze-dried formulations: a new perspective on reformulating naloxone. European Pharmaceutical Review. 2017;3:32-36

12 July 2017 | By , , , ,

References National Institute on Drug Abuse: Overdose Death Rates, https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/national-overdose-deaths2015.pdf (Accessed 24 February 2017) www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2015/estimated-deaths-for-the-four-major-cancers-by-sex-and-age-group-2015.pdf Strang J, Bird SM, Parmar MKB. Take-Home Emergency Naloxone to Prevent Heroin Overdose Deaths after Prison Release: Rationale and Practicalities for the N-ALIVE Randomized Trial. Journal of Urban Health-Bulletin of the New York Academy of…

Bhardwaj V, Gaur V. Raman spectroscopy as a blood glucose monitoring tool. European Pharmaceutical Review. 2017;3:26-29

12 July 2017 | By ,

References International Diabetes Federation. About diabetes, facts and figures 2015 to 2040. Available at: www.idf.org/about-diabetes/what-is-diabetes. Angaran DM, Smith DS, Birnbaum M. The use of urine test for indirect estimation of blood glucose levels in the critically ill. American Journal of Hospital Pharmacy.1980;37:950-956. Clarke SF, Foster JR. A history of blood…

Lankers M, Valet O, Laskina O. Subvisible particle identification in protein-based formulations by Raman spectroscopy. European Pharmaceutical Review. 2017;3:22-24

12 July 2017 | By , ,

References Strehl, R, Rombach-Riegraf V, Diez M, Egodage K, Blueme, M, Jeschke M, Koulov A. Discrimination between silicone oil droplets and protein aggregates in biopharmaceuticals: a novel multiparametric image filter for sub-visible particles in microflow imaging analysis. Pharmaceutical Research. 2012;29(2):594-602. Siska C, Pierini C, Lau H, Latypov R, Fesinmeyer R,…

Gerstberger I, Liebmann M. Regulation of orphan drugs within the EU. European Pharmaceutical Review. 2017;3:14-16

12 July 2017 | By

References Cf. Straeter/Burgardt/Bickmann, Arzneimittel für seltene Leiden – Situation in der Europäischen Union, A&R 2014, 195 with further references. Recital 2 of Regulation (EC) No 141/2000. See also Hiltl, Orphan Drugs – Zwischenbilanz und Konfliktfelder, PharmR 2001, 308. Regulation (EC) No 141/2000 of the European Parliament and of the Council…

Elder D. Separation and purification applications for mutagenic impurities. European Pharmaceutical Review. 2017;3:64-67

12 July 2017 | By

References Fujiwara M, Nagy ZK, Chew JW, Braatz RD. First-principles and direct design approaches for the control of pharmaceutical crystallization. J. Proc. Control. 2005;15:493-504. ICH M7, 2014. Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. Current Step 4 version. 23 June 2014. Teasdale…

Jacobsen NW, Nielsen LD. Two-dimensional liquid chromatography (2D-LC) with multiple heart-cutting in a troubleshooting laboratory. European Pharmaceutical Review. 2017;3:60-63

12 July 2017 | By ,

  References Stoll DR, Li X, Wang X, Carr PW, Porter SEG, Rutan SC. Fast, comprehensive two-dimensional liquid chromatography, J Chromatogr A. 2007;1168(1–2):3-43. doi:10.1016/j.chroma.2007.08.054. Pursch M, Buckenmaier S. Loop-based multiple heart-cutting two-dimensional liquid chromatography for target analysis in complex matrices. Anal Chem. 2015;87(10):5310-7. doi: 10.1021/acs.analchem.5b00492. Chen M, Wang L, Dong…